Skip to main content
Caplight Logo









Leucine

Leucine

Private
Wilmington, DelawareEnterprise Softwarehttps://leucine.ai/

Last Round

Series A

Oct 16, 2023

Est. Valuation

$3.2M

Total Funding Raised

$7.77M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Leucine is a software company that provides an AI-powered platform to help pharmaceutical manufacturers digitize workflows, ensure regulatory compliance, and improve operational efficiency.

Sector

Enterprise Software

Verticals

Quality Management, Smart Manufacturing, Compliance, Workflow Automation, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

manufacturing execution systemMESelectronic batch recordEBRGxP compliancepharma manufacturing softwarequality management systemQMSpharma techAI copilotdigital batch recordvertical SaaScompliance automationsmart manufacturingpharma digital transformation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Leucine Comparables

Compare Leucine with similar companies based on industry and business-model similarity.

Leucine comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Apprentice
86%
Aizon
84%
AmpleLogic
83%

Leucine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 16, 2023
SeedJun 1, 2020
AcceleratorMay 2, 2019

Leucine Investors

Notable investors and investment history

Leucine investors
InvestorRounds
TechstarsSeed, Series A, Accelerator
Axilor VenturesSeed, Series A
Pravega VenturesSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 77% MoM, reaching 17K.

  • Apr 1, 2026

    Launched DWI platform.

Leucine Filings

Explore SEC and related filing metadata, where available.

Leucine filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Leucine's valuation, stock price, and market status.

Is Leucine a public or private company?

Leucine is a private company.

What is the current stock price of Leucine?

Leucine is a private company with no public stock price. No recent secondary market data is available.

How much is Leucine worth (valuation)?

Valuation information for Leucine is not publicly available.

Can I buy Leucine stock?

Leucine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Leucine's last funding round?

Leucine's most recent funding round was Series A on October 16, 2023.

Who are the main investors in Leucine?

Key investors in Leucine include Techstars.

Will Leucine IPO soon?

No public IPO plans have been announced for Leucine.

How can I track Leucine secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Leucine's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWilmington, Delaware
Employee Range104
Year Founded2015
Last FundingOct 16, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?